Glycomimetics inc (GLYC)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Revenue

0

-

-

-

-

-

-

0

-

-

18

18

0

-

0

0

-

-

-

0

-

15,027

15,104

15,156

185

3,992

0

0

0

Costs and expenses:
Research and development expense

47,924

47,029

47,320

46,325

42,562

40,091

35,053

31,104

27,523

24,100

23,440

23,582

23,641

23,281

24,182

23,299

25,361

25,050

23,369

23,382

20,897

19,571

17,411

15,313

12,839

11,701

0

0

0

General and administrative expense

15,439

14,360

13,421

12,830

11,926

11,413

11,299

10,911

10,586

9,832

9,313

8,895

8,686

8,650

8,314

8,463

7,956

7,805

7,960

7,476

7,275

6,595

0

0

0

-

-

-

-

Total costs and expenses

63,364

61,389

60,741

59,156

54,489

51,504

46,353

42,015

38,110

33,932

32,754

32,478

32,327

31,931

32,496

31,762

33,317

32,855

31,330

30,858

28,172

26,166

22,713

19,767

16,356

14,599

0

0

0

Selling, general and administrative expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Loss from operations

-54,364

-61,389

-60,741

-59,156

-54,489

-51,504

-46,353

-42,015

-38,110

-33,932

-32,754

-32,459

-32,309

-31,913

-32,442

-31,727

-13,247

-12,784

-11,295

-10,823

-13,145

-11,139

-7,608

-4,610

-16,171

-10,606

0

0

0

Interest income

2,893

3,497

3,941

4,032

3,410

3,231

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Other income

-

-

-

-

-

-

-

1,743

-

-

402

203

123

-

79

51

31

15

13

15

17

18

13

8

0

-

0

0

-

Loss and comprehensive loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

Income tax (benefit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

-

-

Total other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss and comprehensive loss

-51,470

-57,891

-57,306

-55,629

-51,078

-48,273

-43,390

-39,765

-36,628

-33,281

-32,351

-32,256

-32,186

-31,809

-32,362

-31,676

-13,215

-12,769

-11,281

-10,731

-13,128

-11,121

-7,595

-4,678

-16,167

-10,605

0

0

0

Basic and diluted net loss per common share (in dollars per share)

-0.18

-0.34

-0.31

-0.36

-0.33

-0.39

-0.27

-0.26

-0.26

-0.25

-0.24

-0.30

-0.34

-0.35

-0.34

-0.41

-0.40

-

-0.38

-

-0.37

-

-

-

-0.30

-

-3.00

-

-

Basic and diluted weighted-average number of common shares (in shares)

43,575

43,373

43,295

43,183

43,166

35,489

43,069

42,809

42,809

34,138

32,724

27,239

23,480

23,110

23,049

19,793

19,071

-

19,025

-

18,961

-

-

-

17,232

-

1,233

-

-

Earnings Per Share, Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.55

-

-

-0.35

0.42

-

-

-

-3.70

0.49

Earnings Per Share, Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.51

-

-

-0.35

0.39

-

-

-

-3.70

0.04

Weighted Average Number of Shares Outstanding, Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,011

-

-

18,893

18,807

-

-

-

946

930

Weighted Average Number of Shares Outstanding, Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,236

-

-

18,893

20,238

-

-

-

946

11,128